A cross-sectional survey to investigate the willingness, confidence, and feasibility of pharmacists prescribing antidiabetic medicines

Background: Pharmacist prescribing is undergoing trials in Australia for acute ailments such as uncomplicated urinary tract infections. However, considering the rising prevalence of chronic conditions in Australia and its significant burden on the healthcare system, pharmacist prescribing should also be explored in managing chronic diseases like diabetes.Aim: This study aims to investigate the willingness, confidence, and feasibility of pharmacists in prescribing antidiabetic medications.Methods: A cross-sectional survey was conducted from June to September 2023, targeting pharmacists, and intern pharmacists in New South Wales.Results: Out of 77 candidates who expressed interest in the study, 32 (41.6% response rate) completed the survey. Results revealed that 68.8% were willing to prescribe antidiabetic medications if permitted, regardless of the rurality of work and years of experience. Most (78.1%) were confident in their ability to offer this service, foreseeing benefits for patient health and their careers. While easy access to diabetes training seemed key for implementation, workload from current commitments emerged as a significant barrier.Discussion: Pharmacists are overall willing and confident to prescribe antidiabetic medications if implemented. Ensuring access to adequate training and addressing workload concerns will be pivotal in establishing this service's feasibility for pharmacists.